Do children with ibd really respond better than adults to thiopurines?

Journal of Pediatric Gastroenterology and Nutrition

Volumn 52, Issue 6, 2011, Pages 702-707

  Goodhand, J R ^a   Tshuma, N ^a   Rao, A ^a   Kotta, S ^a   Wahed, M ^a   Croft, N M ^a   Sanderson, I R ^a   Epstein, J ^a   Rampton, D S ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Azathioprine; children compared to adults; Crohn disease; phenotype; ulcerative colitis

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; ADALIMUMAB; AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; INFLIXIMAB; MESALAZINE; PREDNISOLONE; THIOPURINE METHYLTRANSFERASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CROHN DISEASE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENTERITIS; FEMALE; GROUPS BY AGE; HEPATITIS; HUMAN; LABORATORY TEST; LEUKOPENIA; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NAUSEA; PANCREATITIS; PATIENT COMPLIANCE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; RELAPSE; REMISSION; SCHOOL CHILD; SIDE EFFECT; TREATMENT RESPONSE; ULCERATIVE COLITIS; VOMITING;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PURINES; REMISSION INDUCTION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79959240411     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31820ba46c     Document Type: Article

References (31)

1. Sawczenko A, Sandhu BK, Logan RF, et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 2001;357:1093-4. (Pubitemid 32322542)
2. Armitage E, Drummond HE, Wilson DC, et al. Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol 2001;13:1439-47. (Pubitemid 33151496)
3. Vernier-Massouille G, Balde M, Salleron J, et al. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroen-terology 2008;135:1106-13.
4. Van Limbergen J, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel dis-ease. Gastroenterology 2008;135:1114-22.
5. Goodhand J, Dawson R, Hefferon M, et al. Inflammatory bowel disease in young people: the case for transitional clinics. Inflamm Bowel Dis 2010;16:947-52.
6. Markowitz J, Grancher K, Kohn N, et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000;119:895-902.
7. Markowitz J. Early inflammatory bowel disease: different treatment response to specific or all medications? Dig Dis 2009;27:358-65.
8. Punati J, Markowitz J, Lerer T, et al. Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflamm Bowel Dis 2008;14:949-54.
9. Prefontaine E, Macdonald JK, Sutherland LR. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2009:CD000545.
10. Prefontaine E, Sutherland LR, Macdonald JK, et al. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2009:CD000067.
11. Timmer A, McDonald JW, Macdonald JK. Azathioprine and 6-mer-captopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2007:CD000478.
12. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002;8:244-50. (Pubitemid 34784976)
13. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammat orybowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19(Suppl A): 5-36.
14. Wahed M, Louis-Auguste JR, Baxter LM, et al. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine mercaptopurine. AP&T 2009;30:614-20.
15. NRES. Differentiating audit, service evaluation and research. http://www.nresnpsanhsuk/applications/guidance/research-guidance/?entryid 62=66988. Accessed October 1, 2010.
16. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010;362: 1383-95.
17. Summers RW, Switz DM, Sessions JT, et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1979;77:847-69. (Pubitemid 9242048)
18. Sandborn WJ, Tremaine WJ, Wolf DC, et al. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Gastroenterology 1999;117:527-35. (Pubitemid 29409238)
19. Lemann M, Mary JY, Duclos B, et al. Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial. Gastroenterology 2006;130:1054-61.
20. Candy S, Wright J, Gerber M, et al. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 1995;37: 674-8.
21. Present DH, Korelitz BI, Wisch N, et al. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 1980;302:981-7. (Pubitemid 10125406)
22. Sood A, Kaushal V, Midha V, et al. The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis. J Gastroenterol 2002;37:270-4. (Pubitemid 34495524)
23. Sood A, Midha V, Sood N, et al. Role of azathioprine in severe ulcerative colitis: one-year, placebo-controlled, randomized trial. Indian J Gastro-enterol 2000;19:14-6. (Pubitemid 30048938)
24. Hawthorne AB, Logan RF, Hawkey CJ, et al. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ 1992;305: 20-2.
25. Jewell DP, Truelove SC. Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. BMJ 1974;4:627-30.
26. Verhave M, Winter HS, Grand RJ. Azathioprine in the treatment of children with inflammatory bowel disease. JPediatr 1990;117:809-14. (Pubitemid 20382623)
27. Kader HA, Mascarenhas MR, Piccoli DA, et al. Experiences with 6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis. J Pediatr Gastroenterol Nutr 1999;28:54-8. (Pubitemid 29292876)
28. Tajiri H, Tomomasa T, Yoden A, et al. Efficacy and safety of azathiopr-ine and 6-mercaptopurine in Japanese pediatric patients with ulcerative colitis: a survey of the Japanese Society for Pediatric Inflammatory Bowel Disease. Digestion 2008;77:150-4.
29. Hyams JS, Lerer T, Mack DR, et al. Outcome following thiopurine use in children with ulcerative colitis: A prospective multicenter study. http://myddw2010bdmetricscom/SOW-288003030/Topic-Forum-Pediatric- Gastroenterology-Clinical-and-Translational/Overviewaspx. Accessed October 1, 2010.
30. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol 2007;102:1417-26. (Pubitemid 46976288)
31. Greenley RN, Stephens M, Doughty A, et al. Barriers to adherence among adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2010;16:36-41.